HOME >> MEDICINE >> NEWS
Stubborn ulcerative colitis responds to arthritis drug, review finds

In good news for patients with stubborn cases of ulcerative colitis, a serious intestinal disorder, a new research review suggests that the drug infliximab can be a useful alternative if other treatments don't work.

The drug is currently used to treat rheumatoid arthritis and Crohn's disease.

"For people with active ulcerative colitis who do not respond to corticosteroids or immunosuppressive agents, infliximab is effective in inducing clinical remission, inducing clinical response, promoting mucosal healing and reducing the need for colectomy, at least in the short term," said review co-author Dr. Anthony Kwaku Akobeng.

Akobeng, a gastroenterologist at Manchester Children's University Hospitals in England, and colleagues examined seven randomized controlled studies comprising 860 patients that evaluated infliximab as a treatment for ulcerative colitis.

The review of studies appears in the latest issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews like this one draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

"Infliximab is another option if steroids fail," said Peter Higgins, M.D., an assistant professor in gastroenterology at the University of Michigan Medical Center in Ann Arbor.

Still, infliximab "has known infectious risks, which while rare, can be fatal," said Higgins, who was not involved with the review. He added that it's not clear if it's a better option than cyclosporine, another drug commonly used when other medications fail.

The disease afflicts an estimated 600,000 Americans, and occurs when ulcers form in the rectum and colon, leading to frequent diarrhea and bleeding.

According to Higgins, the causes of ulcerative colitis aren't clear, but they may have something to do with an i
'"/>

Contact: Lisa Esposito
lesposito@cfah.org
Center for the Advancement of Health
11-Sep-2006


Page: 1 2 3

Related medicine news :

1. LIALDA -- the first oral once-daily mesalamine for ulcerative colitis -- now available
2. Canada high in ulcerative colitis and Crohns cases: Is Canada too clean?
3. Promising new treatment for ulcerative colitis sufferers
4. Nutritional supplement reduces need for traditional ulcerative colitis treatment
5. Ulcerative colitis remission rates from long-term safety study of LIALDA presented at DDW
6. Ulcerative colitis sufferers find UC quite disruptive to many aspects of daily life
7. Probiotics could prevent necrotising enterocolitis in premature babies
8. Good bacteria helps ease pain of colitis
9. Takeda responds to the FDA advisory committee recommendation
10. American Egg Board responds to proposed USDA rule to revise WIC food package
11. Bradley Hospital responds to FDA report on ADHD drugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/1/2020)... SEATTLE (PRWEB) , ... September 01, 2020 , ... ... that it has completed $3 million convertible note financing, which will be used ... , With the funds from this financing, the company will continue to expand ...
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – today announced the 10th Anniversary of Blood Cancer Awareness Month (BCAM) ...
(Date:8/31/2020)... ... 31, 2020 , ... Colorado State University Global (CSU Global) ... online education – is proud to announce its new master’s degree in ... kind in the nation, the 60-credit hour program is designed to provide students ...
(Date:8/31/2020)... ... August 31, 2020 , ... Dr. Chang ... persons with autism and other developmental disabilities, as well as supporting staff in ... adolescents with autism, school consultation, and staff development. She joined the company in ...
(Date:8/28/2020)... , ... August 28, 2020 , ... ... one-year subscription to a customized Lighthouse Health & Wellness mobile app and web-portal. ... this project. Motorola Solutions Foundation awards grants each year to organizations, such as ...
Breaking Medicine News(10 mins):
(Date:9/1/2020)... Calif. (PRWEB) , ... September 01, 2020 , ... ... analytical laboratory technologies, will host the Agilent Science and Technology Virtual Symposium ... this two-day symposium, Agilent will open a suite of Live webinars and Networking ...
(Date:9/1/2020)... ... 2020 , ... September is National Ovarian Cancer Awareness Month. Ovarian cancer ... cancer of the female reproductive system. The American Cancer Society estimates that in ... will die from this disease. Throughout the month of September, Women’s Excellence aims ...
(Date:8/28/2020)... ... August 28, 2020 , ... Cano Health, LLC, ... in Florida and San Antonio is happy to announce that it has selected ... In this capacity he will serve as community advisor, advertising talent, and creative ...
Breaking Medicine Technology:
Cached News: